【24h】

Targeting the BLyS-APRIL signaling pathway in SLE

机译:靶向SLE中的BLyS-APRIL信号通路

获取原文
获取原文并翻译 | 示例
           

摘要

The B lymphocyte stimulator (BLyS)- A PRoliferation-Inducing Ligand (APRIL) signaling pathway has an important role in the selection, maturation and survival of B cells and plays a significant role in the pathogenesis of systemic lupus erythematosus (SLE). The inhibition of BLyS, a survival factor for transitional and mature B cells, has recently proven to be successful in large phase III clinical trials that led to the approval of an anti-BLyS monoclonal antibody (belimumab) for the treatment of SLE. Yet, there is currently a need to both understand better the mechanisms of action of belimumab in SLE and better define the subsets of patients that are more likely to respond to the drug.
机译:B淋巴细胞刺激物(BLyS)-诱导增殖的配体(APRIL)信号通路在B细胞的选择,成熟和存活中起重要作用,并且在系统性红斑狼疮(SLE)的发病机理中起重要作用。最近,在大型III期临床试验中证明了对BLyS(过渡性和成熟B细胞的生存因子)的抑制作用是成功的,该试验已批准了抗BLyS单克隆抗体(belimumab)用于治疗SLE。但是,目前既需要更好地了解贝利木单抗在SLE中的作用机制,又需要更好地确定更可能对该药产生反应的患者亚群。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号